A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs
Clinical trial NCT01353859 · COMPLETED
Trial details
- NCT number
- NCT01353859
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-07-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.